EUVIMEDEUVIMED entdecken
Crossref

Evidence‐Based Treatment Ladder for Chronic Prostatitis/Chronic Pelvic Pain

Mert Başaranoğlu iD, Ahmet Alper Özdeş iD, Mustafa Sesli iD, Erdem Akbay iD

The Prostate · 2026-04 · 86 (5) · 550-560

DOI: 10.1002/pros.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 18.12.2025. Verfasst von Mert Başaranoğlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mersin University Hospital, Mersin, Turkey. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) affects 2%–10% of men worldwide, yet lacks standardized treatment algorithms. This study aimed to establish a definitive treatment hierarchy by comparing four therapeutic modalities: alpha‐blocker monotherapy, alpha‐blocker plus antibiotic combination, alpha‐blocker plus saw palmetto combination, and transurethral resection of prostate (TUR) surgery. Materials and Methods This retrospective comparative cohort study analyzed 200 adult males with CP/CPPS (50 patients per group) treated at a single academic center between October 2023 and August 2025. Inclusion criteria comprised NIH Chronic Prostatitis Symptom Index (NIH‐CPSI) total score ≥ 10 and pain score ≥ 4, with excluded bacterial infection. Primary endpoint was NIH‐CPSI score improvement at 12 weeks; clinical response was defined as ≥ 6‐point improvement. Secondary endpoints included safety profiles and histopathological findings.

Results

Significant therapeutic efficacy differences emerged between groups ( p < 0.001). TUR surgery achieved highest efficacy with 88% clinical response rate and mean 15.7‐point NIH‐CPSI improvement. Alpha‐blocker plus saw palmetto combination demonstrated superior medical therapy effectiveness (80% clinical response, 10.7‐point improvement), exceeding monotherapy by 4.2 points ( p < 0.001). Critically, alpha‐blocker plus antibiotic combination showed no advantage over monotherapy (6.7 vs 6.5 points, p = 1.000). Chronic prostatitis was histologically confirmed in 100% of TUR specimens, with prostatic stones identified in 76% of cases. All treatments were well‐tolerated with adverse event rates of 18%–30% ( p = 0.234).

Conclusions

This study establishes an evidence‐based treatment hierarchy for CP/CPPS: TUR surgery represents the most effective approach for refractory cases, while alpha‐blocker plus saw palmetto combination constitutes optimal medical therapy. Antibiotic addition provides no benefit in non‐bacterial prostatitis. These findings provide robust evidence for clinical decision‐making and support guideline updates emphasizing antibiotic stewardship and phytotherapeutic agent validation. Clinical Trial Registration This study was not registered as a clinical trial.

Schlagwörter

Stichwörter der Autor:innen

Alpha‐blockersphytotherapysaw palmettotransurethral resectiontreatment algorithmurological therapeutics

Autor:innen und Institutionen

  • Department of Urology, Mersin University Hospital, Mersin, Turkey.
  • Department of Urology, Karakoçan State Hospital, Elazığ, Turkey.
  • Urology Department, Malatya Education and Research Hospital, Malatya, Turkey.

ORCID-Profile: Mert Başaranoğlu, Ahmet Alper Özdeş, Mustafa Sesli, Erdem Akbay

Zitieren

APA

Başaranoğlu, M., Özdeş, A. A., Sesli, M., & Akbay, E. (2026). Evidence‐Based Treatment Ladder for Chronic Prostatitis/Chronic Pelvic Pain. The Prostate, 86(5), 550-560. https://doi.org/10.1002/pros.70114

Vancouver

Başaranoğlu M, Özdeş AA, Sesli M, Akbay E. Evidence‐Based Treatment Ladder for Chronic Prostatitis/Chronic Pelvic Pain. The Prostate. 2026;86(5):550-560. doi:10.1002/pros.70114

BibTeX
@article{Baaranolu2026,
  author = {Başaranoğlu, Mert and Özdeş, Ahmet Alper and Sesli, Mustafa and Akbay, Erdem},
  title = {Evidence‐Based Treatment Ladder for Chronic Prostatitis/Chronic Pelvic Pain},
  journal = {The Prostate},
  year = {2026},
  volume = {86},
  number = {5},
  pages = {550--560},
  doi = {10.1002/pros.70114}
}
Kostenlos starten →